Nifty
Sensex
:
:
24270.85
77763.91
95.15 (0.39%)
261.79 (0.34%)

Chemicals

Rating :
54/99

BSE: 543271 | NSE: JUBLINGREA

678.95
03-Jul-2026
  • Open
  • High
  • Low
  • Previous Close
  •  676.95
  •  688.75
  •  665.65
  •  670.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  346421
  •  234019727.85
  •  851.8
  •  537.3

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,813.60
  • 38.91
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,352.29
  • 0.37%
  • 3.46

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 45.22%
  • 1.93%
  • 17.45%
  • FII
  • DII
  • Others
  • 6.49%
  • 22.77%
  • 6.14%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 43.60
  • -4.34

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 34.69
  • -1.05

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 35.81
  • -6.52

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 36.98
  • 40.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 3.40
  • 3.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 22.82
  • 20.08

Earnings Forecasts:

(Updated: 04-07-2026)
Description
2026
2027
2028
2029
Adj EPS
47
0
28.72
17.35
P/E Ratio
14.45
-
23.64
39.13
Revenue
28.74
23.34
19.54
4406.04
EBITDA
5044.96
5686.63
6540.83
556.87
Net Income
707.83
847.36
989.33
271.11
ROA
369.86
456.34
544.77
8.36
P/B Ratio
1.08
1.10
1.71
3.45
ROE
3.1
2.78
2.46
8.93
FCFF
11.1
12.27
12.9
331.35
FCFF Yield
221.36
335.01
516.68
2.94
Net Debt
1.96
2.97
4.58
804.7
BVPS
630.13
616.45
397.9
196.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
1,178.65
1,051.26
12.12%
1,050.99
1,056.77
-0.55%
1,120.73
1,045.24
7.22%
1,037.95
1,024.34
1.33%
Expenses
1,016.05
904.57
12.32%
924.44
918.48
0.65%
985.21
920.67
7.01%
895.81
914.81
-2.08%
EBITDA
162.60
146.69
10.85%
126.55
138.29
-8.49%
135.52
124.57
8.79%
142.14
109.53
29.77%
EBIDTM
13.80%
13.95%
12.04%
13.09%
12.09%
11.92%
13.69%
10.69%
Other Income
9.31
8.36
11.36%
9.42
9.43
-0.11%
10.81
10.46
3.35%
11.22
9.57
17.24%
Interest
11.81
13.91
-15.10%
12.46
12.39
0.56%
12.16
15.07
-19.31%
12.69
14.27
-11.07%
Depreciation
48.37
39.39
22.80%
45.04
39.76
13.28%
41.23
39.60
4.12%
40.84
38.88
5.04%
PBT
111.73
101.75
9.81%
65.43
95.57
-31.54%
92.94
80.36
15.65%
99.83
65.95
51.37%
Tax
25.27
27.73
-8.87%
18.51
26.20
-29.35%
23.39
21.22
10.23%
24.67
17.29
42.68%
PAT
86.46
74.02
16.81%
46.92
69.37
-32.36%
69.55
59.14
17.60%
75.16
48.66
54.46%
PATM
7.34%
7.04%
4.46%
6.56%
6.21%
5.66%
7.24%
4.75%
EPS
5.48
4.68
17.09%
2.97
4.39
-32.35%
4.40
3.73
17.96%
4.75
3.08
54.22%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
4,388.32
4,177.62
4,135.80
4,772.69
4,949.36
684.13
0.00
Net Sales Growth
5.04%
1.01%
-13.34%
-3.57%
623.45%
0
 
Cost Of Goods Sold
2,294.77
2,107.27
2,142.59
2,581.57
2,839.89
369.95
0.00
Gross Profit
2,093.55
2,070.35
1,993.21
2,191.11
2,109.47
314.18
0.00
GP Margin
47.71%
49.56%
48.19%
45.91%
42.62%
45.92%
0
Total Expenditure
3,821.51
3,658.53
3,714.68
4,225.55
4,117.54
567.01
0.17
Power & Fuel Cost
-
463.54
521.15
709.11
468.23
51.71
0.00
% Of Sales
-
11.10%
12.60%
14.86%
9.46%
7.56%
0
Employee Cost
-
418.05
383.94
343.48
327.28
49.02
0.00
% Of Sales
-
10.01%
9.28%
7.20%
6.61%
7.17%
0
Manufacturing Exp.
-
273.77
275.14
288.14
236.16
56.37
0.00
% Of Sales
-
6.55%
6.65%
6.04%
4.77%
8.24%
0
General & Admin Exp.
-
125.42
146.40
89.68
81.60
12.08
0.17
% Of Sales
-
3.00%
3.54%
1.88%
1.65%
1.77%
0
Selling & Distn. Exp.
-
236.16
207.23
177.84
124.85
21.96
0.00
% Of Sales
-
5.65%
5.01%
3.73%
2.52%
3.21%
0
Miscellaneous Exp.
-
34.32
38.23
35.73
39.52
5.91
0.00
% Of Sales
-
0.82%
0.92%
0.75%
0.80%
0.86%
0
EBITDA
566.81
519.09
421.12
547.14
831.82
117.12
-0.17
EBITDA Margin
12.92%
12.43%
10.18%
11.46%
16.81%
17.12%
0
Other Income
40.76
37.82
35.30
33.37
31.49
2.60
0.00
Interest
49.12
55.64
52.66
21.58
30.94
7.33
0.00
Depreciation
175.48
157.63
136.17
122.18
123.39
22.06
0.00
PBT
369.93
343.64
267.60
436.75
708.99
90.33
-0.17
Tax
91.84
92.44
84.72
129.22
232.23
23.03
0.00
Tax Rate
24.83%
26.90%
31.66%
29.59%
32.76%
29.76%
0.00%
PAT
278.09
251.18
182.89
307.50
476.71
54.36
-0.17
PAT before Minority Interest
278.09
251.18
182.89
307.50
476.71
54.36
-0.17
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.34%
6.01%
4.42%
6.44%
9.63%
7.95%
0
PAT Growth
10.71%
37.34%
-40.52%
-35.50%
776.95%
-
 
EPS
17.46
15.77
11.48
19.30
29.93
3.41
-0.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
2,927.08
2,737.47
2,666.23
2,433.12
1,922.94
-0.12
Share Capital
15.81
15.80
15.90
15.90
15.93
0.05
Total Reserves
2,894.03
2,712.14
2,646.32
2,415.78
1,907.01
-0.17
Non-Current Liabilities
687.05
695.62
403.19
296.32
548.86
0.00
Secured Loans
363.21
425.57
150.00
99.69
455.84
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
66.55
64.81
66.13
67.93
69.44
0.00
Current Liabilities
1,401.00
1,286.08
1,179.58
1,052.78
894.33
0.17
Trade Payables
814.92
766.67
801.12
797.77
694.06
0.17
Other Current Liabilities
232.17
195.23
110.17
101.60
183.03
0.00
Short Term Borrowings
303.95
283.00
246.73
129.06
0.00
0.00
Short Term Provisions
49.95
41.18
21.56
24.34
17.24
0.00
Total Liabilities
5,015.13
4,719.17
4,249.00
3,782.22
3,366.13
0.05
Net Block
2,580.97
2,538.71
1,846.18
1,798.28
1,805.10
0.00
Gross Block
3,617.30
3,443.76
2,625.80
2,462.87
2,352.65
0.00
Accumulated Depreciation
1,036.32
905.04
779.62
664.59
547.56
0.00
Non Current Assets
3,161.90
2,939.27
2,430.99
2,017.65
1,942.54
0.00
Capital Work in Progress
525.18
331.35
524.93
174.22
65.08
0.00
Non Current Investment
20.50
15.49
8.23
6.19
50.24
0.00
Long Term Loans & Adv.
23.91
37.47
42.67
25.86
21.63
0.00
Other Non Current Assets
11.33
16.25
8.97
13.11
0.50
0.00
Current Assets
1,853.22
1,779.90
1,818.00
1,764.57
1,423.59
0.05
Current Investments
16.21
0.00
0.00
0.00
0.00
0.00
Inventories
943.41
941.30
1,035.11
911.16
609.10
0.00
Sundry Debtors
607.13
571.97
510.89
580.91
471.03
0.00
Cash & Bank
98.73
79.60
84.59
48.53
116.60
0.05
Other Current Assets
187.74
47.53
39.26
83.05
226.85
0.00
Short Term Loans & Adv.
135.27
139.50
148.16
140.92
151.85
0.00
Net Current Assets
452.23
493.83
638.43
711.79
529.26
-0.12
Total Assets
5,015.12
4,719.17
4,248.99
3,782.22
3,366.13
0.05

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
508.10
429.98
462.46
452.74
112.28
0.00
PBT
343.62
267.61
436.71
708.94
77.39
-0.17
Adjustment
221.26
202.50
148.28
174.29
45.45
0.00
Changes in Working Capital
22.79
5.87
-45.15
-302.39
0.95
0.17
Cash after chg. in Working capital
587.67
475.98
539.84
580.84
123.79
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-79.57
-46.00
-77.38
-128.10
-11.51
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-392.82
-568.78
-471.89
-71.86
-43.66
0.00
Net Fixed Assets
-177.31
-340.05
-466.36
-217.18
-2,299.50
Net Investments
-12.80
-125.07
-32.70
-4.30
-134.89
Others
-202.71
-103.66
27.17
149.62
2,390.73
Cash from Financing Activity
-128.76
144.13
41.60
-417.75
-72.36
0.05
Net Cash Inflow / Outflow
-13.47
5.34
32.17
-36.87
-3.74
0.05
Opening Cash & Equivalents
78.78
72.72
37.61
73.34
0.05
0.00
Closing Cash & Equivalent
69.36
78.78
72.72
37.61
73.34
0.05

Financial Ratios

Standalone /

Consolidated
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
184.02
172.66
167.47
152.96
120.73
-2.32
ROA
5.16%
4.08%
7.66%
13.34%
3.23%
-332.00%
ROE
8.91%
6.79%
12.07%
21.89%
5.65%
0.00%
ROCE
11.16%
9.80%
16.01%
28.84%
6.86%
0.00%
Fixed Asset Turnover
1.19
1.37
1.88
2.06
0.29
0.00
Receivable days
51.39
47.67
41.69
38.75
250.55
0.00
Inventory Days
82.14
87.01
74.31
56.00
323.99
0.00
Payable days
136.97
133.54
113.03
95.87
342.47
0.00
Cash Conversion Cycle
-3.44
1.13
2.97
-1.12
232.07
0.00
Total Debt/Equity
0.26
0.27
0.15
0.09
0.28
0.00
Interest Cover
7.18
6.08
21.24
23.92
11.56
0.00

News Update:


  • Jubilant Ingrevia - Quarterly Results
    27th May 2026, 00:00 AM

    Read More
  • Jubilant Ingrevia acquires 100% equity stake in Remidex Pharma
    1st Apr 2026, 10:26 AM

    This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4)

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.